World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
23381
World Ranking
17541
National Ranking
8775

Gene P. Siegal publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gene P. Siegal sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 476 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gene P. Siegal D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gene P. Siegal sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Gene P. Siegal is affiliated with the University of Alabama at Birmingham in the United States. Their research spans major fields including Medicine and Biochemistry, Genetics and Molecular Biology, with a notable focus on oncology and molecular mechanisms underlying cancer.

The scientist has a body of work that includes 67 publications in Medicine and 28 in Biochemistry, Genetics and Molecular Biology. Subfields where they have been active include Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, and Rheumatology.

Key topics Gene P. Siegal has explored involve:

  • HER2/EGFR in Cancer Research
  • Sarcoma Diagnosis and Treatment
  • Breast Cancer Treatment Studies
  • Cancer Genomics and Diagnostics
  • Oral and Maxillofacial Pathology
  • Cancer Immunotherapy and Biomarkers
  • Bone Tumor Diagnosis and Treatments

Their recent scientific papers demonstrate a focus on breast cancer pathology and receptor dynamics. These include:

  • Receptor conversion in metastatic breast cancer: analysis of 390 cases from a single institution, 2020, Modern Pathology
  • Characterization of estrogen receptor-low-positive breast cancer, 2021, Breast Cancer Research and Treatment
  • Discordance Between Immunohistochemistry and In Situ Hybridization to Detect HER2 Overexpression/Gene Amplification in Breast Cancer in the Modern Age: A Single Institution Experience and Pooled Literature Review Study, 2021, Clinical Breast Cancer
  • Return of Individual Research Results, 2020, American Journal Of Pathology
  • The dynamics of HER2-low expression during breast cancer progression, 2023, Breast Cancer Research and Treatment

Gene P. Siegal frequently publishes in several venues with multiple contributions including:

  • Modern Pathology (6 publications)
  • UNC Libraries (5 publications)
  • Clinical Breast Cancer (4 publications)
  • Laboratory Investigation (4 publications)
  • Breast Cancer Research and Treatment (3 publications)

The scientist regularly collaborates with a set of co-authors, notable among them:

  • Shi Wei (22 co-authored works)
  • Shuko Harada (12 co-authored works)
  • Xiao Huang (8 co-authored works)
  • Brooke B. Bartow (7 co-authored works)
  • Ceren Yalnız (7 co-authored works)

Best Publications

  • Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

    Paul A. Meyers;Cindy L. Schwartz;Mark D. Krailo;John H. Healey

  • Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

    Paul A. Meyers;Cindy L. Schwartz;Mark Krailo;Eugenie S. Kleinerman

  • Effect of Plasminogen Activator (Urokinase), Plasmin, and Thrombin on Glycoprotein and Collagenous Components of Basement Membrane

    L A Liotta;R H Goldfarb;R Brundage;G P Siegal

  • Loss of basement membrane components by invasive tumors but not by their benign counterparts

    S H Barsky;G P Siegal;F Jannotta;L A Liotta

  • Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate.

    C. K. Goldman;R. L. Kendall;G. Cabrera;L. Soroceanu

  • Osteosarcoma: anatomic and histologic variants.

    Michael J. Klein;Gene P. Siegal

  • Stromal cell–derived factor 1 promotes angiogenesis via a heme oxygenase 1–dependent mechanism

    Jessy Deshane;Sifeng Chen;Sergio Caballero;Anna Grochot-Przeczek

  • Phase II Trial of Trastuzumab in Combination With Cytotoxic Chemotherapy for Treatment of Metastatic Osteosarcoma With Human Epidermal Growth Factor Receptor 2 Overexpression: A Report From the Children's Oncology Group

    David Ebb;Paul Meyers;Holcombe Grier;Mark Bernstein

  • Phase II/III Trial of Etoposide and High-Dose Ifosfamide in Newly Diagnosed Metastatic Osteosarcoma: A Pediatric Oncology Group Trial

    Allen M. Goorin;Michael B. Harris;Mark Bernstein;William Ferguson

  • Loss of Fibroblast Thy-1 Expression Correlates with Lung Fibrogenesis

    James S. Hagood;Priya Prabhakaran;Pallavi Kumbla;Lorena Salazar

  • Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis.

    Yan Y. Sanders;Annie Pardo;Moisés Selman;Gerard J. Nuovo

  • Breast cancer subtypes predispose the site of distant metastases.

    Abha Soni;Zhiyong Ren;Omar Hameed;Omar Hameed;Diptiman Chanda

  • Targeted Gene Delivery to Kaposi's Sarcoma Cells via the Fibroblast Growth Factor Receptor'

    Corey K. Goldman;Buck E. Rogers;Joanne T. Douglas;Barbara A. Sosnowski

  • Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma.

    Mariam A Stoff-Khalili;Angel A Rivera;J Michael Mathis;N Sanjib Banerjee

  • Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma.

    Hiroshi Sasaki;Hiroshi Nishii;Hiroyuki Takahashi;Akio Tada

  • 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells.

    G G Schwartz;M H Wang;M Zang;R K Singh

  • Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses.

    Anna Kanerva;Minghui Wang;Gerd J. Bauerschmitz;John T. Lam

  • A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial.

    Ronald D. Alvarez;Mack N. Barnes;Jesus Gomez-Navarro;Minghui Wang

  • Sarcomas of bone complicating osteitis deformans (Paget's disease): fifty years' experience.

    M R Wick;G P Siegal;K K Unni;R A McLeod

  • Immunohistochemistry in the evaluation of neovascularization in tumor xenografts.

    Dezhi Wang;Cecil R Stockard;Louie Harkins;Patricia Lott

Frequent Co-Authors

David T. Curiel
David T. Curiel Washington University in St. Louis
Ronald D. Alvarez
Ronald D. Alvarez Vanderbilt University Medical Center
Akseli Hemminki
Akseli Hemminki University of Helsinki
William E. Grizzle
William E. Grizzle University of Alabama at Birmingham
Selvarangan Ponnazhagan
Selvarangan Ponnazhagan University of Alabama at Birmingham
Lance A. Liotta
Lance A. Liotta George Mason University
Jay M. McDonald
Jay M. McDonald University of Alabama at Birmingham
Victor Krasnykh
Victor Krasnykh The University of Texas MD Anderson Cancer Center
Holcombe E. Grier
Holcombe E. Grier Harvard University
Jaroslaw W. Zmijewski
Jaroslaw W. Zmijewski University of Alabama at Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While studying Medicine in the USA is a popular choice, there are many alternative and related career pathways worth exploring. Online degrees offer flexibility, affordability, and access to a variety of healthcare professions beyond the traditional MD route.

For those interested in a hands-on role in patient care, consider the easiest rn program to get into or research lpn to rn programs without teas test. These nursing pathways can provide entry points into the profession with streamlined admission requirements.

For students more interested in the administrative side of healthcare, earning a degree in healthcare administration could open doors to management roles in hospitals, clinics, or insurance companies.

If you prefer working with data and records, consider exploring the best medical billing and coding schools online. This field is essential for maintaining the smooth operation of healthcare facilities and offers robust job growth.

Best Scientists Citing Gene P. Siegal

Trending Scientists

Recently Published Articles